Hong Kong stock exchange filings reveal that on August 20, Cowin China Growth Fund II, L.P. reduced its holdings in INNOGEN-B (02591) by 860,000 shares, with each share priced at HK$4.3373, bringing the total transaction value to approximately HK$3.73 million.

Following the reduction, the fund's latest share count stands at around 24.1564 million shares, representing a 5.75% stake in the company. The filing also lists related entities, including Cowin Capital Investment III Limited, Cowin Capital Investment II LTD, and Cowin Capital Investment Limited.